Physician

Ahmed Maki, DO

According to 2025 Medicare claims, Ahmed Maki, DO (NPI: 1457507998) practices otolaryngology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is GEOFFREY TRENKLE DO A PROFESSIONAL MEDICAL CORPORATION (NPI: 1992124978; TIN: 465185290) and primary practice location at 91206-4172.

Maki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 2,075 HCPCS/CPT codes, and received $171,915 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 2,965 prescription claims across 1,026 beneficiaries totaling $93,024 in drug costs, led by Azelastine Hcl (Azelastine Hcl). Open Payments data shows 40 records totaling $2,789. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $45,534 to $171,915. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,186 to $93,024. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$86K$172K2017 Medicare payment: $45,534 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $129,986 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $136,172 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $25,161 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,272 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $105,520 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $49,629 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $171,915 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201795248$45,534
20182611,497$129,986
20193041,548$136,172
2020155334$25,161
20211725$2,272
20222971,040$105,520
2023178848$49,629
20246172,075$171,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$61K$123K2015 Drug cost: $1,186 (USD; Tot_Drug_Cst)2016 Drug cost: $4,253 (USD; Tot_Drug_Cst)2017 Drug cost: $8,861 (USD; Tot_Drug_Cst)2018 Drug cost: $22,355 (USD; Tot_Drug_Cst)2019 Drug cost: $34,129 (USD; Tot_Drug_Cst)2020 Drug cost: $33,288 (USD; Tot_Drug_Cst)2021 Drug cost: $29,351 (USD; Tot_Drug_Cst)2022 Drug cost: $67,539 (USD; Tot_Drug_Cst)2023 Drug cost: $122,586 (USD; Tot_Drug_Cst)2024 Drug cost: $93,024 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152634$1,186
201662137$4,253
2017150364$8,861
2018261797$22,355
20194331,268$34,129
20203961,136$33,288
2021330933$29,351
20226612,038$67,539
20239612,767$122,586
20241,0262,965$93,024

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
31231Diagnostic exam of nasal passages using an endoscope7187$167
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more283283$131
31575Diagnostic exam of voice box using a flexible endoscope6075$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more375555$106
69210Removal of impacted ear wax140171$39

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Azelastine HclAzelastine Hcl71031,745$13,788
XhanceFluticasone Propionate20990$11,848
Ipratropium BromideIpratropium Bromide41219,339$10,986
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth741,186$7,316
Fluticasone PropionateFluticasone Propionate64927,120$6,553

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$2,789AERIN MEDICAL INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Maki, DO?

Tedicare shows public-source Medicare data for Ahmed Maki, DO (NPI 1457507998), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Maki, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmed Maki, DO?

Ahmed Maki, DO is linked to GEOFFREY TRENKLE DO A PROFESSIONAL MEDICAL CORPORATION (billing NPI 1992124978) in the available physician profile data.

Does Ahmed Maki, DO have Open Payments data?

Ahmed Maki, DO has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.